|
|
| Line 4: |
Line 4: |
| | {{dgfn2015 So 7:00 Hyperuricemia}} | | {{dgfn2015 So 7:00 Hyperuricemia}} |
| | {{dgfn2015 Mo 7:00 PCSK9}} | | {{dgfn2015 Mo 7:00 PCSK9}} |
| − | {{dgfn2015 }} | + | {{dgfn2015 So 16:30 Membranöse / mir378a /Mifepriston}} |
| | {{dgfn2015 }} | | {{dgfn2015 }} |
| | {{dgfn2015 }} | | {{dgfn2015 }} |
Revision as of 06:31, 18 September 2015
There are quite a lot of citations, data on - paper. Lets start with the Hyperuricemia lecture from so 7:00
Sa Opening - On the comparative physiology of men, mice and bears
sorry no citations collected
So 7:00 Hyperuricemia
Extra paper fresh from nephroVIP twitter
| Journal article, free access
|
| GET 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Extract PDF direct
|
| Journal article, free access
|
| GET Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial Extract PDF direct
|
| Journal article, free access
|
| GET Uric acid and chronic kidney disease: which is chas ing which? Extract PDF direct
|
| Journal article, free access
|
| GET A slight increase within the normal range of serum uric acid and the decline in renal function: associations in a community-based population Extract PDF direct
|
| Journal article, free access
|
| GET Uric acid and incident kidney disease in the community Extract PDF direct
|
| Journal article, free access
|
| GET Elevated uric acid increases the risk for kidney disease Extract PDF direct
|
| Journal article, free access
|
| GET Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study Extract PDF direct
|
| Journal article, free access
|
| GET Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study Extract PDF direct
|
| Journal article, free access
|
| GET High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up Extract PDF direct
|
| Journal article, free access
|
| GET Effect of urate-lowering therapies on renal disease progression in patients with hyperuricemia Extract PDF direct
|
- ndt 2015;..:1 doi10.1693/ndt/gfv222 wrong citation
| Journal article, free access
|
| GET Febuxostat compared with allopurinol in patients with hyperuricemia and gout Extract PDF direct
|
| Journal article, free access
|
| GET Effect of allopurinol in chronic kidney disease progression and cardiovascular risk Extract PDF direct
|
| Journal article, free access
|
| GET Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial Extract PDF direct
|
| Journal article, free access
|
| GET Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial Extract PDF direct
|
| Journal article, free access
|
| GET The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study Extract PDF direct
|
| Journal article, free access
|
| GET Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis Extract PDF direct
|
| Journal article, free access
|
| GET Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis Extract PDF direct
|
| Journal article, free access
|
| GET The independent association between serum uric acid and graft outcomes after kidney transplantation Extract PDF direct
|
- wrong cit jasn 2009 4 1655
| Journal article, free access
|
| GET Effects of hyperuricemia on renal function of renal transplant recipients: a systematic review and meta-analysis of cohort studies Extract PDF direct
|
| Journal article, free access
|
| GET Uric acid: a novel risk factor for acute kidney injury in high-risk cardiac surgery patients? Extract PDF direct
|
- missing citation j urol 2002
| Journal article, free access
|
| GET Metabolic basis for low urine pH in type 2 diabetes Extract PDF direct
|
| Journal article, free access
|
| GET Gout, stone composition and urinary stone risk: a matched case comparative study Extract PDF direct
|
| Journal article, free access
|
| GET Randomized trial of allopurinol in the prevention of calcium oxalate calculi Extract PDF direct
|
| Journal article, free access
|
| GET Randomized controlled trial of febuxostat versus allopurinol or placebo in individuals with higher urinary uric acid excretion and calcium stones Extract PDF direct
|
| Journal article, free access
|
| GET Kidney stones and the risk for chronic kidney disease Extract PDF direct
|
eof.
DGFN2015 Neue Wirkansätze in der Hyperlipidämie - Stellenwert für die Nephrologie (Rump-LC,Gouni-Berthold-I)
Session Videos
Lipidmanagement bei CKD-Patienten, Was ist belegt, was zu beachten. (Wanner-W)
| Journal Paper, restricted access
|
| GET A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease Extract PDF direct
|
| Journal Paper, restricted access
|
| GET Implementation of the KDIGO guideline on lipid management requires a substantial increase in statin prescription rates Extract PDF direct
|
| Journal Paper, restricted access
|
| GET The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia Extract PDF direct
|
| Journal Paper, restricted access
|
| GET Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Extract PDF direct
|
PCSK9-Inhibitoren: ein neuer Wirkmechanismus (Schettler-V)
| Journal Paper, restricted access
|
| GET A century of cholesterol and coronaries: from plaques to genes to statins Extract PDF direct
|
| Journal Paper, restricted access
|
| GET The biology and therapeutic targeting of the proprotein convertases Extract PDF direct
|
| Journal article, free access
|
| GET Plasma membrane CD81 complexes with PCSK9 and LDLR and its levels are reduced by PCSK9 Extract PDF direct
|
| Journal Paper, restricted access
|
| GET Protease variants, LDL, and coronary heart disease Extract PDF direct
|
| Journal article, free access
|
| GET Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia Extract PDF direct
|
| Journal Paper, restricted access
|
| GET Mutations in PCSK9 cause autosomal dominant hypercholesterolemia Extract PDF direct
|
| Journal Paper, restricted access
|
| GET Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis Extract PDF direct
|
| Journal article, free access
|
| GET Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease Extract PDF direct
|
| Journal article, free access
|
| GET Sequence variations in PCSK9, low LDL, and protection against coronary heart disease Extract PDF direct
|
| Journal article, free access
|
| GET Longitudinal association of PCSK9 sequence variations with low-density lipoprotein cholesterol levels: the Coronary Artery Risk Development in Young Adults Study Extract PDF direct
|
| Journal article, free access
|
| GET The biology of PCSK9 from the endoplasmic reticulum to lysosomes: new and emerging therapeutics to control low-density lipoprotein cholesterol Extract PDF direct
|
| Journal Paper, restricted access
|
| GET Antihyperlipidemic therapies targeting PCSK9 Extract PDF direct
|
| Journal Paper, restricted access
|
| GET Pharmacotherapies for lipid modification: beyond the statins Extract PDF direct
|
| Journal article, free access
|
| GET Lipids and CVD management: towards a global consensus Extract PDF direct
|
| Journal article, free access
|
| GET High-dose atorvastatin causes a rapid sustained increase in human serum PCSK9 and disrupts its correlation with LDL cholesterol Extract PDF direct
|
| Journal Paper, restricted access
|
| GET The role of PCSK9 in intestinal lipoprotein metabolism: synergism of statin and ezetimibe Extract PDF direct
|
| Journal article, free access
|
| GET A 52-week placebo-controlled trial of evolocumab in hyperlipidemia Extract PDF direct
|
| Journal Paper, restricted access
|
| GET Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial Extract PDF direct
|
| Journal article, free access
|
| GET AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C Assessment with Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined with Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 trial Extract PDF direct
|
| Journal Paper, restricted access
|
| GET Lipoprotein(a) mass: a massively misunderstood metric Extract PDF direct
|
| Journal article, free access (Hinweis: wrong paper ??? 2015;15:41 Schettler)
|
| GET Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels Extract PDF direct
|
| Journal article, free access
|
| GET Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis Extract PDF direct
|
Was kommt nach den Statinen ? Aktuelles zu PCSK9 Antikörpern (König-W)
| Journal article, free access
|
| GET Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials Extract PDF direct
|
| Journal Paper, restricted access
|
| GET Meta-analysis of comparative efficacy of increas.ing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids (from VOYAGER) Extract PDF direct
|
| Journal Paper, restricted access
|
| GET Efficacy and safety of evolocumab in reducing lipids and cardiovascular events Extract PDF direct
|
Membranöse Glomerulonephritis / mirna378 / paranormale Steroidwirkungen
Antigene der memGN
| Journal article, free access
|
| GET M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy Extract PDF direct
|
| Journal article, free access
|
| GET Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy Extract PDF direct
|
| Journal article, free access
|
| GET Early-childhood membranous nephropathy due to cationic bovine serum albumin Extract PDF direct
|
| Journal article, free access
|
| GET PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy Extract PDF direct
|
mir-378a in MCNS/FSGS
keine References. Sehr interessant, da mirnosomale 378a ein kandidat für das chronisch unbekannte permeabilitätssteigernde zytokin sein könnte.
mirna 378a sei tgfbeta responsiv im podoyten, i.u. in fsgs mcns und inhibiert npnt fibronectin damit pro emt-like metaplasie wie im zebrafisch gezeigt. sehr schöne arbeit.
Therapie der memGN
| Journal article, free access
|
| GET Idiopathic membranous nephropathy: definition and relevance of a partial remission Extract PDF direct
|
Ziation wie dargestellt nicht zu finden deshalb nächstähnlich:
| Journal article, free access
|
| GET 2012. The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient Extract [{{{pdf}}} PDF direct]
|
| Journal article, free access
|
| GET 2010. Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial Extract PDF direct
|
| Journal article, free access
|
| GET 2010. Alkylating agents in membranous nephropathy: efficacy proven beyond doubt Extract PDF direct
|
| Journal article, free access
|
| GET 2007. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy Extract PDF direct
|
| Journal article, free access
|
| GET 2015. Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy Extract PDF direct
|
| Journal article, free access
|
| GET 2015. Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody negative patients with membranous nephropathy Extract [ PDF direct]
|
Steroide hin & her ; retarget Mifepriston
| Journal article, free access
|
| GET 1950. Increased sodium-retaining corticoid excretion in edema, with some observations on the effects of cortisone in nephrosis Extract PDF direct
|
| Journal article, free access
|
| GET 2015. Excess prenatal corticosterone exposure results in albuminuria, sex-specific hypotension, and altered heart rate responses to restraint stress in aged adult mice Extract PDF direct
|
| Journal article, free access
|
| GET 2011. Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis Extract PDF direct
|
| Journal article, free access
|
| GET 2012. Subtotal ablation of parietal epithelial cells induces crescent formation Extract PDF direct
|
| Journal Paper, restricted access
|
| GET 2014. The emergence of the glomerular parietal epithelial cell Extract PDF direct
|
| Journal article, free access
|
| GET 2012. Parietal epithelial cells and podocytes in glomerular diseases Extract PDF direct
|
Template:Dgfn2015
Template:Dgfn2015
Template:Dgfn2015
Template:Dgfn2015
Template:Dgfn2015
Template:Dgfn2015
Template:Dgfn2015
Template:Dgfn2015
Template:Dgfn2015
Template:Dgfn2015
Template:Dgfn2015
Template:Dgfn2015
Template:Dgfn2015
Template:Dgfn2015
Template:Dgfn2015
